Issue link: http://www.e-digitaleditions.com/i/853645
Inhalation August 2017 19 Automated actuation for every device Proveris Vereo ® Automated Actuators are designed to replicate human usage of devices through automated actua- tion. Accurate control of actuation by force or position allows spray devices to be actuated precisely and consistently. e Vereo ® actuator product family covers a full range of orally inhaled and nasal spray devices for superior spray characterization in the Proveris SprayVIEW ® measurement systems, or on the bench, to assist with delivered dose uniformity and aerodynamic particle size distribution testing. Viota ® Software provides a powerful, yet simple to use, user interface with real time, force-position feedback measured and displayed as actuation profiles. Proveris Scientific Corporation US: +1 508 460-8822 www.proveris.com New USP Chapter: Test methods for MDIs with spacers and VHCs e newly published US Pharmacopoeia Chapter <1602> details additional requirements for testing metered dose inhalers (MDIs) when used with spacers and valved holding chambers (VHCs), both with and without facemasks. It calls for particle characterization tests which recognize that the inhaled therapeutic dose depends on patient interac- tion with the add-on device. Copley Scientific has a suite of products to meet these requirements, including the BRS 1100 and new BRS 2100 breath simulators, the Breath Actuation Controller BAC 2000, the Facemask Testing Apparatus (FMA) and the NGI to FMA Interface Accessory. Such equipment allows the application of specific inha- lation profiles for neonate, infant, child and/or adult patients during dose uniformity testing and time delays during cascade impaction to reflect clinical practice. Copley Scientific UK: +44 1159 616229 www.copleyscientific.com